United States v. J. Harris Morgan, Jr.

452 F. App'x 866
CourtCourt of Appeals for the Eleventh Circuit
DecidedNovember 30, 2011
Docket11-10026
StatusUnpublished
Cited by3 cases

This text of 452 F. App'x 866 (United States v. J. Harris Morgan, Jr.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. J. Harris Morgan, Jr., 452 F. App'x 866 (11th Cir. 2011).

Opinion

PER CURIAM:

J. Harris Morgan, Jr. appeals his convictions for 69 counts of health care fraud, in violation of 18 U.S.C. § 1347. On appeal, he argues that: (1) there is insufficient evidence to uphold his convictions; (2) the district court abused its discretion by admitting evidence of uncharged false healthcare claims, in violation of Federal Rule of Evidence 404(b); and (3) the court abused its discretion by refusing to give the good faith jury instruction that Morgan requested. For the reasons set forth below, we affirm Morgan’s convictions.

I.

Morgan, a pharmacist, owned Thrift Center Pharmacy (“Thrift”) and Option Care. Thrift was a pharmacy provider with Georgia Medicaid. Morgan was charged with 69 counts of health care fraud, in violation of § 1347. Specifically, 58 of those counts alleged that he had submitted, and instructed others to submit, false claims regarding Synagis to Georgia Med *868 icaid. The indictment alleged that Morgan submitted claims for larger doses of Syn-agis than were actually dispensed, false diagnoses to obtain approval to administer Synagis, and claims for Synagis more often than it was actually being administered to the patients. The final 11 counts alleged that Morgan submitted false claims for Hepatitis C drugs, Nutropin AQ, and “other drugs.” These counts alleged that Morgan submitted to Georgia Medicaid: (1) false claims stating that larger doses of the drugs were administered than had actually been dispensed to the patients; (2) claims stating that the drugs were administered at an earlier date than they actually were; and (3) claims for the drugs more often than they were ordered by the patients’ physicians.

Morgan filed a pretrial motion for disclosure of evidence to be offered under Rule 404(b). The court set a deadline by which the government was to disclose any such evidence.

According to the trial testimony, Synag-is was a medication given to premature infants and young children to prevent them from contracting respiratory syncy-tial virus (“RSV”). It was sold in 50 and 100 milligram vials. It was administered monthly during the RSV season, which ran from September until April during the time period at issue in this case. Pharmacists or physicians were required to obtain prior approval from Medicaid before administering Synagis to a Medicaid patient. When deciding whether to approve the use of Synagis, Medicaid considered the patient’s age, diagnosis, risk factors for RSV, and other diseases the patient had. If Medicaid denied approval to administer Synagis, the pharmacist or physician had 72 hours to update the information and seek approval.

Joyce Sheppard testified that she was the billing clerk at Thrift. She did most of the Medicaid Synagis billing. Morgan had not given her instructions on how to submit Synagis claims, but he did tell her to bill it every 23 days. Billing that frequently allowed Thrift to pay its bills and ensure that the patients’ insurance would cover the medication. Sheppard was concerned that she would submit too many Synagis bills, but she did not remember if she had ever told Morgan that it was hard to keep up with the 23-day billing cycle.

Nancy Palmer, a registered nurse, testified that she had previously worked as the nursing director at Option Care. Morgan was actively involved in managing his businesses, and he did whatever work was needed, including working in the pharmacy, taking doctor’s orders, and keeping up with administrative and billing issues. He and Sheppard handled the Synagis billing. Morgan told Sheppard to submit the Syn-agis claims every 23 days, to bill as early in the month as possible, and to submit the claims even if she did not know how much Synagis the nurses had actually administered. .This system was “very chaotic,” but Morgan maintained that it was necessary to ensure that he was able to pay the supplier for the Synagis. Palmer also testified that she and her coworkers determined that patients diagnosed with bronchopulmonary dysplasia (“BPD”) were automatically approved to receive Synagis. Palmer learned that two employees were using a diagnosis of BPD to obtain prior approval for Synagis even if the patient’s physician had not indicated that the patient had BPD. Morgan told Palmer that all of the patients had BPD and that they would continue to use that diagnosis.

Rhianna Williams, a licensed practical nurse, testified that she was the Synagis coordinator at Option Care. Morgan was at Thrift on a daily basis, he ran the staff meetings where patients were discussed, *869 and Williams had observed him billing Synagis. Williams and Paige Shiver generally obtained prior approval for Synagis. A few times when a patient was denied approval for Synagis, Morgan told Williams and Shiver to say that the patient was diagnosed with BPD even though the patient’s doctor had not made that diagnosis. After doing so, the patients were approved to receive Synagis. When Williams and Shiver decided that they would no longer provide false diagnoses, Morgan, on a few occasions, obtained approval for patients. Both the government and Morgan’s attorney reviewed patient files with Williams, and she testified that those files showed claims submitted as soon as 4 days after the prior claim was submitted and as late as 29 days after the prior claim was submitted. Additionally, Williams reviewed four patients’ charts. Those patients had each received 8 doses of Synagis, but 9, 10, 11, and 12 claims were submitted to Medicaid for the patients respectively.

Shiver testified that she had previously worked as a pharmacy technician at Thrift and Option Care. When she told Morgan that she would not provide false diagnoses to Medicaid, he told her to leave the files with him because he would take care of them. She testified that Total Parenteral Nutrition (“TPN”) was a nutritional supplement administered to patients at their homes. Morgan objected that the government had not notified him of its intent to introduce evidence regarding TPN as required by Rule 404(b). The government argued that TPN was an “other drug” and that TPN claims were part of Morgan’s scheme to defraud Medicaid as alleged in the final 11 counts in the indictment. The court overruled the objection, finding that Rule 404(b) did not apply because the evidence fell within the indictment’s general allegations. Shiver then testified that it was inappropriate to submit a claim for TPN for a hospitalized patient, but she nonetheless saw such claims submitted by Morgan. Morgan conducted clinical staff meetings, at which the staff discussed which patients were hospitalized and thus did not need medicine prepared. Shiver saw TPN over-billings submitted by Morgan about twice a month.

Denise Colson, a state healthcare auditor, testified that Thrift had billed Medicaid for 7,524 100-milligram vials of Synag-is, but it had only purchased 5,256 100-milligram vials of the drug.

Cynthia Vassell, a registered nurse and a state healthcare auditor, testified that she had reviewed Morgan’s patient files for patients receiving Hepatitis C drugs. She identified instances where more Hepatitis C drugs were billed than the patient would have needed based on the patient’s weight and other instances where Medicaid was billed for more refills than would have been administered.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
452 F. App'x 866, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-j-harris-morgan-jr-ca11-2011.